Non-invasive biomarkers for early detection of breast cancer

J Li, X Guan, Z Fan, LM Ching, Y Li, X Wang, WM Cao… - Cancers, 2020 - mdpi.com
Simple Summary Early diagnosis of breast cancer greatly increases the chance of cure and
survival from the disease. The mammogram is widely used for early detection of breast …

Association of circulating tumor DNA with disease-free survival in breast cancer: a systematic review and meta-analysis

C Cullinane, C Fleming, DP O'Leary… - JAMA network …, 2020 - jamanetwork.com
Importance Fragmented DNA is continuously released into the circulation following
apoptosis and necrosis of both cancerous and noncancerous cells; when it is released by …

Liquid biopsy in breast cancer: a focused review

TKY Tay, PH Tan - Archives of Pathology & Laboratory …, 2021 - meridian.allenpress.com
Context.—The role of liquid biopsy in cancer management has been gaining increased
prominence in the past decade, with well-defined clinical applications now being …

[HTML][HTML] Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis

AS Zangouei, M Zangoue, N Taghehchian… - Biological …, 2023 - SciELO Chile
Cell cycle is one of the main cellular mechanisms involved in tumor progression. Almost all
of the active molecular pathways in tumor cells directly or indirectly target the cell cycle …

[HTML][HTML] Liquid biopsy in the clinical management of cancers

HY Ho, KS Chung, CM Kan, SC Wong - International Journal of Molecular …, 2024 - mdpi.com
Liquid biopsy, a noninvasive diagnosis that examines circulating tumor components in body
fluids, is increasingly used in cancer management. An overview of relevant literature …

Advances in breast cancer screening modalities and status of global screening programs

C Luo, L Wang, Y Zhang, M Lu, B Lu, J Cai… - Chronic Diseases and …, 2022 - mednexus.org
Breast cancer (BC) is the most prevalent malignancy worldwide, and a continued upward
trend has been predicted in the coming decades. Screening in selected targeted …

Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancer

R Banerjee, I Maitra, T Bhattacharya… - Critical Reviews in …, 2024 - Elsevier
Triple-negative breast carcinoma (TNBC) is one of the most challenging subtypes of breast
carcinoma and it has very limited therapeutic options as it is highly aggressive. The …

Metastatic breast cancer: cytology diagnosis with implications for treatment

A Hrizat, E Brachtel - Journal of Molecular Pathology, 2022 - mdpi.com
Breast cancer is among the most frequent malignancies in women worldwide. While early
detection and effective treatment provide many women with a cure and prevent their cancer …

[HTML][HTML] Impact of Molecular Profiling on Therapy Management in Breast Cancer

F Ultimescu, A Hudita, DE Popa, M Olinca… - Journal of Clinical …, 2024 - mdpi.com
Breast cancer (BC) remains the most prevalent cancer among women and the leading
cause of cancer-related mortality worldwide. The heterogeneity of BC in terms of …

Liquid biopsy in breast cancer: circulating tumor cells and circulating tumor DNA

TK Yoo - Translational Research in Breast Cancer, 2021 - Springer
Cancer is associated with gene mutations, and the analysis of tumor-associated mutations is
increasingly used for diagnostic, prognostic, and treatment purposes. These molecular …